4.2 Article

Synergistic inhibition of lipid peroxidation by vitamin E and a dopamine agonist, cabergoline

Journal

NEUROLOGICAL RESEARCH
Volume 26, Issue 4, Pages 418-421

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1179/016164104225016029

Keywords

dopamine agonist; cabergoline; antioxidant; vitamin E; Parkinson's disease

Ask authors/readers for more resources

We examined antioxidant activity of cabergoline, a dopamine agonist, during the aerobic oxidation of phosphatidylcholine liposomes at 37degreesC Cabergoline retarded the oxidation initiated with a lipid-soluble initiator significantly better than that with a water-soluble initiator, suggesting that cabergoline locates in the lipid layer of liposomal membranes. Cabergoline inhibited the oxidation of liposomal membranes synergistically with endogenous antioxidants such as ascorbic acid, ubiquinol-10 and vitamin E, and vitamin E was the most efficient synergist. These results suggest that cabergoline may have a neuroprotective effect on the substantia nigra of Parkinsonian patients because of its synergistic antioxidant activity with vitamin E as well as its action on dopamine receptor.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available